These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7665053)

  • 1. [Tumor biology-oriented treatment concepts in gynecologic oncology].
    Graeff H
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):M27-31. PubMed ID: 7665053
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stage adjusted therapy of malignancies and breast cancers].
    Frobenius W; Tulusan AH; Lang N
    Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):M51-6. PubMed ID: 8013849
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of local control in an era of systemic therapy.
    Hellman S; Weichselbaum RR
    Nat Clin Pract Oncol; 2005 Feb; 2(2):60-1. PubMed ID: 16264859
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carcinoma with carcinoid differentiation. Differential diagnostic interpretation of an unusual malignant breast tumor].
    Prechtel K; Wurster K; Dittmar FW; Schierwarter B; Schünemann W
    Pathologe; 1993 Jan; 14(1):25-9. PubMed ID: 8451223
    [No Abstract]   [Full Text] [Related]  

  • 5. Principles of adjuvant therapy.
    Dawson JW; Taylor I
    Br J Hosp Med; 1995 Sep 20-Oct 3; 54(6):249-54. PubMed ID: 8542172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of metastatic breast cancer--2].
    Brockmann B; Reitzig P; Dietzmann A; Cyganiak P
    Z Arztl Fortbild (Jena); 1994 Apr; 88(4):305-9. PubMed ID: 8053233
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology of tumor markers in breast cancer management: prognostic markers.
    Page DL
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):101-4. PubMed ID: 8049630
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems and medical need for after-care in gynecologic oncology].
    Schmidt-Matthiesen H
    Gynakologe; 1989 Feb; 22(1):9-19. PubMed ID: 2541056
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
    Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D
    Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytostatic polychemotherapy plans integrated into the multimodal treatment of malignant gynecologic neoplasms. III].
    Bild E; Dragomir D
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(3-4):323-32. PubMed ID: 1823458
    [No Abstract]   [Full Text] [Related]  

  • 13. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer.
    Moon YW; Jeung HC; Rha SY; Choi YH; Yang WI; Chung HC
    Breast Cancer Res Treat; 2007 Jul; 104(1):31-7. PubMed ID: 17587181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients with locally recurrent breast cancer.
    Voogd AC; van Tienhoven G
    Am J Surg; 2007 Jan; 193(1):138. PubMed ID: 17188110
    [No Abstract]   [Full Text] [Related]  

  • 17. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
    Kreienberg R
    Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
    [No Abstract]   [Full Text] [Related]  

  • 18. Palliative approaches to the patient with breast cancer.
    Bartus CM; Schreiber JS; Kurtzman SH
    Surg Oncol Clin N Am; 2004 Jul; 13(3):517-30, ix. PubMed ID: 15236733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
    Schnitt SJ
    Am J Clin Pathol; 2003 Oct; 120(4):485-8. PubMed ID: 14560560
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
    Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
    Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.